The WACC of Lineage Cell Therapeutics Inc (LCTX) is 8.9%.
| Range | Selected | |
| Cost of equity | 7.50% - 10.30% | 8.90% |
| Tax rate | 4.20% - 6.50% | 5.35% |
| Cost of debt | 7.00% - 10.40% | 8.70% |
| WACC | 7.5% - 10.3% | 8.9% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.79 | 0.97 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.50% | 10.30% |
| Tax rate | 4.20% | 6.50% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 7.00% | 10.40% |
| After-tax WACC | 7.5% | 10.3% |
| Selected WACC | 8.9% | |